{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T20:38:19Z","timestamp":1771706299863,"version":"3.50.1"},"reference-count":23,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3441,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0404.2006.00590.x","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T17:07:46Z","timestamp":1279991266000},"page":"322-326","source":"Crossref","is-referenced-by-count":8,"title":["Increased frequency of rapid acetylator genotypes in patients with brain astrocytoma and meningioma"],"prefix":"10.1155","volume":"113","author":[{"given":"M.","family":"Olivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Alonso-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J.","family":"Jim\u00e9nez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A. G.","family":"Ag\u00fandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,3,31]]},"reference":[{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB1|cit2","first-page":"2010","volume-title":"Harrison's principles of internal medicine","author":"Hochberf","year":"1991"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB2|cit3","unstructured":"Doll RPR. Causes of cancer Oxford University Press"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB3|cit4","first-page":"27","article-title":"Metabolic polymorphisms and cancer susceptibility","volume":"25","author":"Smith","year":"1995","journal-title":"Cancer Surv"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB4|cit5","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB5|cit6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/bj2970441","article-title":"Chromosomal localization of human genes for arylamine N-acetyltransferase","volume":"297","author":"Hickman","year":"1994","journal-title":"Biochem J"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB6|cit7","first-page":"118","article-title":"NAT2 genotyping: equilibrium between accuracy and feasibility in routine analyses","volume":"3","author":"Agundez","year":"2003","journal-title":"J Appl Res"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB7|cit8","first-page":"24","article-title":"Acetylator status, drug metabolism and disease","volume":"16","author":"Pande","year":"2003","journal-title":"Natl Med J India"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB8|cit9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0300-483X(02)00450-X","article-title":"The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer","volume":"118-2","author":"Vineis","year":"2002","journal-title":"Toxicology"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB9|cit10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00008571-199508000-00004","article-title":"Lung cancer and mutations at the polymorphic NAT2 gene locus","volume":"5","author":"Martinez","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB10|cit11","first-page":"15","article-title":"Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain","volume":"45","author":"El-Bacha","year":"1999","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB11|cit12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0006-2952(97)00671-0","article-title":"Metabolism of xenobiotics in the central nervous system: implications and challenges","volume":"56","author":"Ravindranath","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.1991.tb08266.x","article-title":"Acetylation of serotonin in the rabbit pineal gland: an N-acetyltransferase with properties distinct from NAT1 and NAT2 is responsible","volume":"57","author":"Heim","year":"1991","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB13|cit14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/378783a0","article-title":"Diurnal variation in mRNA encoding serotonin N-acetyltransferase in pineal gland","volume":"378","author":"Borjigin","year":"1995","journal-title":"Nature"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB14|cit15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0197-0186(95)00031-3","article-title":"Arylamine and arylalkylamine N-acetyltransferases in retina, pineal gland, brain and liver of chicks: a comparative study","volume":"27","author":"Nowak","year":"1995","journal-title":"Neurochem Int"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB15|cit16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1389200043335621","article-title":"Cytochrome P450 gene polymorphism and cancer","volume":"5","author":"Agundez","year":"2004","journal-title":"Curr Drug Metab"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB16|cit17","first-page":"118","article-title":"Biochemical, molecular genetic and ecogenetic studies of polymorphic arylamine N-acetyltransferase (NAT2) in the brain","volume":"90","author":"Ogawa","year":"1999","journal-title":"Fukuoka Igaku Zasshi"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB17|cit18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00008571-199610000-00006","article-title":"Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population","volume":"6","author":"Agundez","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB18|cit19","first-page":"553","article-title":"Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas","volume":"7","author":"Trizna","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB19|cit20","first-page":"151","article-title":"NAT2 and NQO1 polymorphisms are not associated with adult glioma","volume":"10","author":"Peters","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB20|cit21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.37.1.269","article-title":"Molecular mechanisms of genetic polymorphisms of drug metabolism","volume":"37","author":"Meyer","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB21|cit22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/carcin\/19.5.873","article-title":"Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells","volume":"19","author":"Stone","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB22|cit23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/carcin\/14.8.1633","article-title":"Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases","volume":"14","author":"Hein","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1600-0404.2006.00590.x-BIB23|cit24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1023\/A:1020335430016","article-title":"Berberine-inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T\/VGH) and brain glioblastoma multiforms (GBM 8401) cells","volume":"27","author":"Wang","year":"2002","journal-title":"Neurochem Res"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2006.00590.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2006.00590.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:43:30Z","timestamp":1671540210000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2006.00590.x"}},"subtitle":["NAT2 genotype in brain tumors"],"short-title":[],"issued":{"date-parts":[[2006,3,31]]},"references-count":23,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00590.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,31]]}}}